Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria
NCT01360658
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Solar Urticaria
Interventions
DRUG:
Intravenous immunoglobulins
Sponsor
Centre Hospitalier Universitaire de Besancon
Collaborators
[object Object]
[object Object]